Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Percutaneous transvenous mitral annuloplasty: Initial human experience with a novel coronary sinus implant device
Circulation: Cardiovascular Interventions, 06/25/09
Sack S et al. – Percutaneous implantation of a novel coronary sinus mitral repair device (PTMA) is feasible and safe. Acute results show a possibly meaningful reduction of mitral regurgitation (MR) in responding pts. Sustained favorable geometric modification of the mitral annulus is reported, despite limited reduction of MR.
Methods- Study of the safety and feasibility of permanent implantation of PTMA device
- Subjects: symptomatic (NYHA class 2 or 3) pts with primarily functional MR
- Diagnostic PTMA procedure in coronary sinus venous continuity
- Assessment of MR, then PTMA device adjustment to optimize efficacy
- PTMA implant placement attempted if MR reduction (≤1 grade)
- Echocardiographic, quality of life, and exercise capacity metrics evaluation of implanted pts
- Diagnostic PTMA study for 19 pts
- Diagnostic PTMA effective in 13 pts: MR grade 3.2±0.6 reduced to 2.0±1.0
- PTMA implants placed in 9 pts
- Uneventful removal of 4 devices (7, 84, 197, 216 days), 3 for annuloplasty surgery due to observed PTMA device migration and/or diminished efficacy
- No procedure or device-related major adverse events with permanent sequela in any diagnostic or implant pts
- Sustained reductions of mitral annulus septal-lateral dimension from 3D echo reconstruction dimensions (4.0±1.2 mm at 3 mo)
Related Articles
Percutaneous Mitral Annuloplasty with the VIACOR Coronary Sinus System for the Treatment of Functional Mitral Regurgitation in Heart Failure Patients. Development and Results
Herz, 10/08/09
Relevance Score: 80%
Percutaneous Mitral Valve Annuloplasty with the Carillon Mitral Contour System by Cardiac Dimensions. A Minimally Invasive Therapeutic Option for the Treatment of Severe Functional Mitral Valve Regurgitation
Herz, 10/08/09
Relevance Score: 80%
The Role of Imaging in Percutaneous Mitral Valve Repair
Herz, 10/07/09
Relevance Score: 80%
Insight Into the Dynamics of the Coronary Sinus/Great Cardiac Vein and the Mitral Annulus
Circulation: Cardiovascular Interventions, 11/16/09
Relevance Score: 79%
Hybrid Therapy of Radiofrequency Catheter Ablation and Percutaneous Transvenous Mitral Commissurotomy in Patients With Atrial Fibrillation and Mitral Stenosis
Journal of Cardiovascular Electrophysiology, 10/13/09
Relevance Score: 79%
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: The ACTION experience
International Journal of Cardiology, 12/14/09
Patient Comprehension of an Interactive, Computer-Based Information Program for Cardiac Catheterization
Archives of Internal Medicine, 12/14/09
Prehospital 12-Lead ECG to Triage ST-Elevation Myocardial Infarction and Emergency Department Activation of the Infarct Team Significantly Improves Door-to-Balloon Times
Circulation: Cardiovascular Interventions, 12/03/09
Today in Valvular Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Rheumatic heart disease and its control in the Pacific
Expert Review of Cardiovascular Therapy , 12/15/09
Outcomes of reoperative aortic valve replacement after previous sternotomy
The Journal of Thoracic and Cardiovascular Surgery, 12/15/09
Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid
International Journal of Infectious Diseases, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


